Home » Newsletters » BioWorld Asia

BioWorld Asia

July 28, 1999

View Archived Issues

Cerep, Bristol-Myers Align In Broad Deal Worth $43M

EU Debate, Confusion Continue Over Confined Use Of GMOs

Bacterium's Ability To Stimulate T Cells Could Lead To Vaccine

Ovarian Cancer Gene Therapy Enters Phase II/III in Germany

MolecularNature Focuses On Plant-Based Compounds

Canadian Start-Up Working On New Approach To Cancer

PPL Uses Gene Targeting To Produce Two Lambs

AdProTech Compound Shows Promise In Animal Models

Cortecs Gets Termination Milestone From Partner

Oxford Biomedica, Modex Enter Insulin-Delivery Deal

NiCox Starts Phase II Trial At Two Centers In France

Genset Isolates Genes Associated With Responses To Asthma Drug

Queensland Researchers Link Cancer Protein To Cholesterol

Animal Data Lead Researchers To Possible MG Therapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.